The diagnostic utility of alpha-glutathion e S-transferase (aGST) in the assessment of acute hepatotoxicity was compared with a range of markers including alanine aminotransferas e (ALT) and aspartate aminotransferas e (AST). Rats were given a single oral dose of either a-naphthylisothiocynate (ANIT), bromobenzen e (BrB), or thioacetamide (TAM) at concentrations previously shown to induce marked hepatotoxicity. The progression of each hepatic lesion was monitored by the measurement of a battery of markers, including aGST, in plasma collected at time points ranging from 3 h to 7 days after dosing. aGST was seen to increase signi cantly at 24 h (ANIT/BrB) and 3 h (TAM) postdosing, correspondin g with histopathologica l ndings. For each compound, when the degree of insult was most severe, fold increases in aGST were greater than those seen with ALT and AST, yet lower than those seen with glutamate dehydrogenas e (BrB and ANIT), sorbitol dehydrogenas e (TAM), or total bilirubin and bile acids (ANIT). Elevations in aGST were also detected no earlier than any other marker. aGST in the rat was shown to be a valid marker of hepatotoxicity ; however, its measuremen t offered no additional information in detecting either the time of onset/recovery or the severity of each type of hepatic injury induced.
INTRODUCTION
The glutathione S-transferases (EC 2.5.1.18) form a complex family of multifunctional proteins displaying various biological functions (3) , their main purpose being the phase II detoxi cation of xenobiotics. This family of enzymes consists of cytosolic isoforms (alpha, mu, pi, and theta) as well as a more recently isolated microsomal form (6) . In humans, 80% of all alpha-glutathione S-transferase (aGST) is found within the liver (6) where it comprises 5-10% of the soluble hepatic protein (7) . This has resulted in much interest in the measurement of aGST, via the use of species speci c enzyme immunoassays (EIA) (8, 12) , as a superior marker of hepatotoxicity. Further advantages, such as its cytosolic localization, small size (M r 50,000), and short half-life (approximately 90 min), potentially offer more information regarding acute changes to hepatocellular integrity than other markers such as alanine aminotransferase (ALT) (EC 2.6.1.2) and aspartate aminotransferase (AST) (EC 2.6.1.1).
Traditionally, ALT and AST are the enzymes most commonly used in the assessment of hepatocellular status. Nevertheless, it is recognized that both ALT and AST are more abundant within the periportal region of the liver lobule (6) , and as such, their utility in the assessment of centrilobular or midzonal hepatotoxicity may be questioned. AST has a ubiquitous distribution (5) with signi cant activities in the heart, liver, kidney, and skeletal muscle, respectively. It should therefore not solely be used as an indicator of liver damage unless other supporting enzymes are measured. Investigations using the rat have been performed by several groups, comparing the utility of aGST with the transaminases, using carbon tetrachloride (1, 2, 6, 7) and bromobenzene (2) . Both of these compounds are recognized to induce centrilobular necrosis; the region of the liver known to have lower levels of ALT and AST. Little published data is available comparing the diagnostic utility of aGST in comparison to markers other than ALT or AST.
It was therefore decided to compare the diagnostic utility of aGST in the assessment of hepatic injury induced by different toxins in comparison with a wide range of liver injury markers including ALT, AST, glutamate dehydrogenase (GLDH) (EC 1.4.1.3), sorbitol dehydrogenase (SDH) (EC 1.1.1.14), and alkaline phosphatase (ALP) (EC 3.1.3.1). In addition, markers of liver dysfunction were measured, including total bile acids (BA) and total bilirubin (T-bil), as well as correlation to histopathological ndings.
Preliminary work using allyl alcohol, Nnitrosodiethylamine (NDEA), and N-nitrosodimethylamine (NDMA) as hepatotoxins generated progressive liver lesions of varying severity in a dose-dependent manner. Despite the varying degrees of insult seen, aGST was not seen to increase any more signi cantly than alternate parameters measured at any time point. It was recognized, however, that the time points at which samples were collected on these studies (either 24 or 48 h and 168 h postdose) did not address the early onset of the hepatic injury. Based on these data, it was decided to investigate the potential of aGST as a marker of acute hepatotoxicity further, by monitoring the progression of differing hepatic lesions over a greater range of time points.
The model hepatotoxins a-naphthylisothiocynate (ANIT) (10, 11) , bromobenzene (BrB) (9) , and thioacetamide (TAM) (13) were chosen to induce varying zonal patterns of hepatic insult. Previous studies with these compounds have shown that they elicit hepatotoxicity within 24-48 h, indicated by elevations in ALT and AST.
As BrB and TAM have also been described as potent nephrotoxic agents (4), renal function was monitored by the measurement of plasma creatinine and urea.
MATERIALS AND METHODS Animals
Male Wistar Han rats [crl:WI(Glx/BRL/Han)BR] aged 10-11 weeks (BrB), 8-9 weeks (ANIT), and 9-10 weeks (TAM) were used. Each animal was housed singly throughout the study with food and water available ad libitum. All animals were checked twice daily for signs of ill health and body weights, and clinical observations were performed daily. All studies were performed in accordance with Home Of ce guidelines speci c for GlaxoSmithKline Research and Development.
Bromobenzene, a-Naphthylisothiocynate, and Thioacetamide Studies
Rats were administered a single oral dose of BrB (1.5 g/kg), ANIT (150 mg/kg), or TAM (150 mg/kg) and autopsied at 3, 7, 24, 31, and 168 h postdose (n 5 rats/toxin/time point). Each compound was obtained from Sigma Aldrich, Poole, Dorset, and formulated in corn oil to give a nal dose volume of 10 ml/kg. All control animals were dosed with corn oil only. Final autopsies were performed at 54 and 72 h postdose, rather than 168 h, for animals treated with BrB and TAM, respectively, due to animal ill health (progressive weight loss and persistently hunched posture). Vehicle control animals, dosed with corn oil only, were autopsied at 24 and 31 h (n 5 rats/time point).
Sample Collection
At each time point, 0.6 ml blood was taken from each animal, via aortic exsanguination under iso urane anesthesia, into heparinized microtainers (Becton Dickinson, Plymouth, UK). Samples were centrifuged at room temperature (15-25 C) within 1 h of blood collection and plasma was separated for analysis. Plasma for aGST analysis was frozen at 15 to 25 C until required. All other parameters were measured using fresh plasma, stored at 2-8 C, within 24 h of collection.
Tissue Collection and Slide Preparation
At each time point postadministration of BrB, ANIT, or TAM, the following tissues were xed in 10% buffered formalin, conventionally processed, and sectioned before staining with hematoxylin and eosin: heart, kidney (right), liver, esophagus, spleen, stomach, testes (right), bladder, and cerebral cortex.
Tissue Enzyme Distribution and Freeze-Thaw Study-Tissue Homogenate Preparation
Samples of liver, heart, skeletal muscle, kidney, testes, spleen, and small intestine were obtained from anesthetized male rats (n 1). These were taken into 10 mM phosphatebuffered saline (PBS) and frozen at 75 to 85 C until required. Tissues were homogenized in a ratio of 1 g tissue per 10 ml PBS (chilled) using an Ultra-Turrax T8 homogenizer. The resultant suspension was centrifuged at 4 C at 6000 rpm for 15 min. The supernatant was removed and stored at 2-8 C prior to analysis. The samples were diluted in sample speci c diluent (aGST) and 10 mM PBS (ALT, AST, aGST, GLDH, SDH, and ALP).
Subsequently, liver was collected from anesthetized male rats (n 3) into 10 mM PBS. Homogenates of each liver were prepared, as described earlier, using sections of each liver, pre-and postfreezing. Homogenates prepared from fresh (n 3) and frozen liver (n 3) were each analyzed for ALP, ALT, AST, GLDH, and SDH. aGST was assayed in homogenate prepared from fresh (n 1) and frozen liver (n 1).
aGST Analysis aGST was measured using the Hepkit-Rt enzyme immunoassay (Biotrin International, Dublin, Ireland). The assay procedure is based upon the sequential addition of sample, antibody-enzyme conjugate, and substrate to microwells coated with anti-rat aGST immunoglobulin G (IgG). The resultant color formation was proportional to the aGST concentration within the sample. The assay range was 0-100 l g/L. Plate washing was performed using a Wave 100 automated plate washer (Dynex Technologies, Ashford, Middlesex). Curve tting and data handling were performed automatically using an MRX automated plate reader (Dynex Technologies).
Spectrophotometric Analysis
All parameters were measured at 37 C using a Hitachi 917 automated clinical chemistry analyzer (Roche Diagnostics Limited, Lewes, UK). Reagents for ALT and AST (without pyridoxal -5 -phosphate), GLDH, ALP (diethanolamine buffer), T-bil, creatinine (Jaffe method), and urea were supplied by Roche Diagnostics, while SDH and BA reagents were supplied by Sigma Aldrich (Poole, Dorset).
Study Data Handling
Data are expressed in terms of fold increase from control mean values (n 10) at each time point (n 5). Statistical signi cance of changes in any parameter was determined using Student's unpaired t-test.
RESULTS

Tissue Distribution
Tissue distribution studies (Figures 1-3 ) showed the abundance of aGST within the liver and kidney. Measurable amounts of aGST were detectable in testes and spleen, although to a much lesser degree. The tissue distribution of GLDH and SDH is comparable to aGST, with liver and kidney being the primary sources. AST activity, as expected, was found in a majority of tissues examined, most notably the heart, liver, kidney, and skeletal muscle. Enzyme analysis was performed on homogenates made from fresh and frozen livers for comparison. aGST and ALT were relatively unaffected by the freeze-thaw process; however, SDH showed a marked loss of activity. AST and GLDH were both signi cantly increased after the freezing process. postdose, elevations in AST, SDH, GLDH, and aGST were detected. In addition, signi cant increases in ALT, BA, and Tbil were noted at 31 h. Of the selected time points, the highest measured levels of all parameters were seen at 54 h postdose. Most notable of these were GLDH and aGST (increased 339and 134-fold over control values, respectively). No changes in plasma creatinine or urea were seen throughout the study.
Histopathology. BrB resulted in multifocal liver necrosis within 24 to 31 h. By 54 h all animals showed marked or very marked centrilobular necrosis. In the kidney, slight to moderate numbers of hyaline droplets were present in the proximal tubules of the majority of animals killed at 24 to a-Naphthylisothiocynat e Study Clinical Chemistry. No signi cant increases were seen in liver enzymes at 3 and 7 h after dosing ( Figure 5 ). T-Bil was observed to increase at 3 h and remained elevated throughout the study. Of the selected time points, the highest measured levels of all parameters were seen at 31 h postdose. Most notable of these were BA and T-bil, which were increased 38-and 35-fold over control values, respectively. No changes in plasma creatinine or urea were seen throughout the study.
Histopathology. Following a single oral dose of ANIT, progressive biliary and periportal necrosis was observed in the liver of animals killed at 3, 7, 24, and 31 h postdose. Evidence of partial recovery of these changes was seen at 168 h postdose. Centrilobular hepatocytes remained unaffected throughout the study. In the testes, treatment-related changes (spermatid retention, tubular epithelial vacuolation) were seen in a single male killed at 3 h postdose. No changes were seen in other males killed at this time point or in males killed at 7, 24, or 31 h postdose. At 168 h postdose, sperm retention was apparent in all animals (to be reported subsequently). In the spleen, a slight to moderate increase in the degree of extramedullary hematopoiesis was seen in all animals killed 168 h postdose. No treatment-related effects were seen in the heart, kidney, esophagus, stomach, bladder, or cerebral cortex.
Thioacetamide Study
Clinical Chemistry. Signi cant elevations in SDH, GLDH, aGST, and BA were seen at 3 h ( Figure 6 ).
Elevations were seen in all parameters by 7 h, with each remaining elevated throughout the study. Of the selected time points, aGST, SDH, and BA peaked at 24 h with fold increases of 123, 1213, and 58, respectively. AST, ALT, and GLDH peaked later, at 31 h, with fold increases of 140, 60, and 69, respectively. All parameters showed partial recovery by 72 h, however, all remained elevated. Between 7 and 72 h postdose, plasma creatinine and urea levels increased twoand threefold over control values, respectively.
Histopathology. Following a single dose of TAM, very slight periportal in ammatory in ltration of the liver was present at 3 h (Figure 7 ). This increased in severity by 7 h, and was accompanied by biliary hyperplasia, centrilobular in ammation, and multifocal single-cell necrosis. At 24 and 31 h, marked centrilobular necrosis with in ammation, had developed, the severity of which had declined by 72 h. In the kidney, slight tubular foaminess of the medullary rays was present at 7 h. By 24 and 31 h this change had progressed such that vacuolar degeneration of the medullary rays was seen. This persisted until 72 h, by which time regenerative changes were also present. Within the spleen, very slight to slight lymphocytolysis was present in most animals. No treatment-related ndings were observed in the heart, testes, esophagus, stomach, bladder, or cerebral cortex.
DISCUSSION
Preliminary studies using the hepatotoxic agents allyl alcohol, NDEA, and NDMA (data not shown) were inconclusive regarding the diagnostic utility of aGST in the assessment of acute hepatotoxicity. As a result, subsequent studies using BrB, ANIT, and TAM were performed.
The results of these studies show that aGST is a viable marker of hepatotoxicity in the Wistar Han rat, correlating well with changes in other indicators of hepatic injury. aGST has been reported as a marker of acute hepatotoxicity (2, 6, 12) . Nevertheless, given each of the compounds studied, signi cant elevations in plasma aGST were seen no earlier than elevations in any other marker. This is in contrast to studies performed using carbon tetrachloride (CCl 4 ), which show aGST to be signi cantly increased several hours prior to those seen in plasma AST levels (6) . Furthermore, increases in aGST were lower than with GLDH (BrB and ANIT), SDH (TAM), or T-bil (ANIT) when compared to control levels. However, for each hepatotoxin, aGST was typically increased more signi cantly than either AST or ALT, correlating well with previous reports (6) . The timing of enzyme release into the plasma and their subsequent decrease was consistent with the histopathological changes seen with each compound. This time-dependent increase in plasma enzymes, including aGST, is consistent with previously reported ndings in which CCl 4 (1, 2, 6, 7) and BrB (2) , have been used as model hepatotoxins.
It has been reported that aGST (M r 50,000) may increase within the circulation at an earlier time point than other enzyme markers (6) such as AST (M r 92,000), GLDH (M r 300,000), SDH (M r 140,000), and ALT (M r 110,000), given its relative smaller size. However, there was no obvious correlation between enzyme molecular weight and magnitude or time of appearance in the plasma seen in any of the studies performed.
Tissue enzyme distribution studies show that to accurately assess hepatic injury, a panel of markers should be used rather than a single marker in isolation. Although a single enzyme may exist more abundantly in a particular tissue, it is typically distributed among varying organs in the body. Therefore, its elevation within the circulation may re ect damage to this main organ but may additionally re ect damage to tissues that express the same enzyme to a lesser degree, as can sometimes be observed with the measurement of AST. In this investigation the distribution of aGST correlated with the respective locations of GLDH, SDH, and ALT in terms of their relative abundance in the liver. Additionally, with reference to all other tissues, the comparable abundance of aGST, GLDH and SDH, within the kidney was identi ed.
From the freeze-thaw experiment (Figure 3) , it was seen that both AST and GLDH increased signi cantly in homogenate preparations using previously frozen liver samples. The loss of SDH activity postfreezing was also an important nding, illustrating its greater utility if measured on fresh sample material. Levels of aGST and ALT remained relatively unaffected in the homogenate prepared from previously frozen liver tissue.
A single oral dose of BrB induced a marked degree of centrilobular necrosis. aGST, like other plasma markers was not increased before 24 h after dosing ( Figure 4 ). Although at 54 h aGST was increased more signi cantly than both ALT and AST, it was elevated to a lesser extent than GLDH. The more pronounced increases in aGST in comparison to ALT and AST at 24, 31, and 54 h may re ect the hepatic lobular localization of each enzyme, with aGST being recognized as more ubiquitous throughout the liver than the transaminases and their reported periportal prevalence (6) . Although slight changes in renal tubules were seen in the majority of animals at 24 and 54 h, there was no degeneration of these cells, and hence release of intracellular contents from these cells into the blood is unlikely.
Administration of ANIT induced periportal necrosis and in ammatory changes consistent with that expected (10) . This compound was recognized to cause intrahepatic cholestasis within 16 to 24 h of administration, and therefore its use to induce acute hepatobiliary toxicity and furthermore to assess the utility of aGST in the detection of this lesion was not ideal. However, ANIT did induce changes within the por-tal region and, as such, allowed direct comparison of aGST with ALT and AST in the assessment of this type of injury. While aGST was elevated to a greater extent than ALT and AST at 24 and 31 h after dosing, it did not increase or decrease more rapidly than any other parameter. In comparison to aGST, GLDH was the most signi cantly increased liver enzyme at 24 and 31 h postdose. However, the hepatobiliary lesion induced by ANIT administration was best indicated by elevations in total plasma BA and most notably T-bil. An unexpected testicular pathology was noted in a single animal at 3 h, although no concomitant elevations in aGST, ALP, or AST were detected.
TAM induced a biphasic pattern of hepatotoxicity, with periportal in ammation (3-7 h) preceding centrilobular necrosis and apparent periportal recovery (24-72 h) ( Figure 7) . In contrast with BrB and ANIT treatment, elevations in plasma enzymes were detected at 3 h following TAM administration. As well as SDH, GLDH, and BA, this included aGST, which was elevated to a greater degree than both ALT and AST at this time point. By 7 h each parameter was signi cantly increased with respect to control values, most notably SDH, which remained the most sensitive parameter throughout the study. With TAM-induced hepatic insult, concordant elevations in plasma enzymes were not observed, as seen with both BrB and ANIT treatment. aGST reached its highest concentration in the plasma at 24 h, decreasing by 72 h. GLDH, ALT, and AST continued to increase until 31 h before decreasing. aGST, SDH, GLDH, ALT, and AST still remained elevated at 72 h postdose. Nephrotoxicity was apparent histopathologically between 24 and 72 h, supported by increases in plasma creatinine of 33.9-148% and urea of 66.9-183% on these occasions. This severity of renal toxicity may therefore be contributory to the apparent increases in plasma aGST, ALP, AST, GLDH, and SDH. It is typically recognized that markers of renal injury are excreted into the urine; however, in the presence of signi cant renal damage, their reabsorption and thus appearance in the circulation should not be discounted.
The rat speci c aGST enzyme immunoassay (EIA) is simple to use and performs well. Intra-and interassay precision, sensitivity, and linearity were monitored throughout each study, and the data produced were consistent with those quoted by the manufacturer (data not shown). However, the assay, including sample preparation, takes approximately 4 h. The cost per test of aGST ($18.20) is also considerably higher than other markers such as ALT ($0.08) and GLDH ($1.20). As such, it is a labor-and cost-intensive assay in comparison to the automated spectrophotometric assays discussed.
At no time point in any of the three studies did aGST offer any additional information regarding hepatocellular integrity compared to alternate parameters measured. aGST was generally shown to be a more sensitive marker of hepatic injury than ALT and AST, corresponding to previously published reports (6) , while other markers such as GLDH, SDH, or T-bil were shown to more effectively indicate the differing types of damage induced.
In conclusion, aGST in the Wistar Han rat was shown to be a valid marker of these types of induced hepatotoxicity. However, the measurement of aGST offered no additional information in detecting either the time of onset/recovery or the severity of each type of hepatic injury induced, in comparison to the panel of markers already established within this laboratory.
